TY  - JOUR
AU  - Martín-Hernández, Elena
AU  - Quijada-Fraile, Pilar
AU  - Correcher, Patricia
AU  - Meavilla, Silvia
AU  - Sánchez-Pintos, Paula
AU  - de Las Heras Montero, Javier
AU  - Blasco-Alonso, Javier
AU  - Dougherty, Lucy
AU  - Marquez, Ana
AU  - Peña-Quintana, Luis
AU  - Cañedo, Elvira
AU  - García-Jimenez, María Concepción
AU  - Moreno Lozano, Pedro Juan
AU  - Murray Hurtado, Mercedes
AU  - Camprodon Gómez, María
AU  - Barrio-Carreras, Delia
AU  - de Los Santos, Mariela
AU  - Del Toro, Mireia
AU  - Couce, María L
AU  - Vitoria Miñana, Isidro
AU  - Morales Conejo, Montserrat
AU  - Bellusci, Marcello
PY  - 2022
DO  - 10.3390/jcm11175045
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/21339
T2  - Journal of clinical medicine
AB  - Background and objectives: Glycerol phenylbutyrate (GPB) has demonstrated safety and efficacy in patients with urea cycle disorders (UCDs) by means of its clinical trial program, but there are limited data in clinical practice. In order to analyze the...
LA  - en
KW  - clinical practice
KW  - glycerol phenylbutyrate (GPB)
KW  - sodium benzoate (NaBZ)
KW  - sodium phenylbutyrate (NaPB)
KW  - urea cycle disorders (UCDs)
TI  - Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain.
TY  - research article
VL  - 11
ER  -